Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Operating Expenses | 1,724 | 1,143 | 950 | 1,437 | 1,497 |
| Operating Income | -1,724 | -1,143 | -950 | -1,437 | -1,497 |
| Other Income | 140 | 198 | 216 | 229 | 245 |
| Pre-tax Income | -1,584 | -945 | -734 | -1,208 | -1,252 |
| Net Income Continuous | -1,584 | -945 | -734 | -1,208 | -1,252 |
| Net Income | $-1,584 | $-945 | $-734 | $-1,208 | $-1,252 |
| EPS Basic Total Ops | -0.13 | -0.07 | -0.06 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.13 | -0.08 | -0.06 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.13 | -0.07 | -0.06 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.13 | -0.08 | -0.06 | -0.10 | -0.10 |
| EBITDA(a) | $-1,716 | $-1,135 | $-947 | $-1,434 | $-1,495 |